These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2986832)

  • 1. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
    Bunk MJ; Kinahan JJ; Sarkar NH
    Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
    Bunk MJ; Telang NT; Higgins PJ; Traganos F; Sarkar NH
    Nutr Cancer; 1985; 7(1-2):105-15. PubMed ID: 2999720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
    Mehta RG; Hultin TA; Moon RC
    Biochem J; 1988 Dec; 256(2):579-84. PubMed ID: 2851995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of malignant transformation upon the cellular retinoid binding proteins in cultured murine mammary cells.
    Bunk MJ; Telang NT; Sarkar NH
    Cancer Lett; 1983 Aug; 20(1):83-92. PubMed ID: 6318967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
    Smith JE; Lawless DC; Green MH; Moon RC
    J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
    Sani BP; Shealy YF; Hill DL
    Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
    Abou-Issa H; Curley RW; Alshafie GA; Weiss KL; Clagett-Dame M; Chapman JS; Mershon SM
    Anticancer Res; 2001; 21(6A):3839-44. PubMed ID: 11911255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and metabolic retinoid pathways in the human ocular surface.
    Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
    Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences.
    Berni R; Formelli F
    FEBS Lett; 1992 Aug; 308(1):43-5. PubMed ID: 1386578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of the interactions between retinoid-binding proteins and embryonal carcinoma cells.
    Barkai U; Sherman MI
    J Cell Biol; 1987 Mar; 104(3):671-8. PubMed ID: 3029143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of several retinoid binding proteins resulting from retinoic acid-induced differentiation of F9 cells.
    Eriksson U; Hansson E; Nilsson M; Jönsson KH; Sundelin J; Peterson PA
    Cancer Res; 1986 Feb; 46(2):717-22. PubMed ID: 3000582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
    Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
    Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of N-(4-hydroxyphenyl) retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin.
    Holven KB; Natarajan V; Gundersen TE; Moskaug JO; Norum KR; Blomhoff R
    Int J Cancer; 1997 May; 71(4):654-9. PubMed ID: 9178822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(4-hydroxyphenyl)-retinamide increases lecithin:retinol acyltransferase activity in rat liver.
    Matsuura T; Zhao Z; Ross AC
    J Nutr; 1996 Oct; 126(10):2474-80. PubMed ID: 8857507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
    Swanson BN; Newton DL; Roller PP; Sporn MB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):632-7. PubMed ID: 6170750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats.
    Schaffer EM; Ritter SJ; Smith JE
    J Nutr; 1993 Sep; 123(9):1497-503. PubMed ID: 8360775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells.
    Chertow BS; Moore MR; Blaner WS; Wilford MR; Cordle MB
    Diabetes; 1989 Dec; 38(12):1544-8. PubMed ID: 2555241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats.
    Adams WR; Smith JE; Green MH
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):178-85. PubMed ID: 7831350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.